Last year, Moderna Inc generated 1.81B USD for its biggest-performing segment, COVID. The United States made the largest contribution, accounting for 1.20B USD last year. For the latest quarter, Moderna Inc reported the revenue of 91.00M USD for the period ending 2026-06-30, which came from the top-performing segment, COVID. United States contributed the highest revenue, at 70.00M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

COVID

RSV

FY2025

FY2024

COVID

1.81B(99.56%)

3.08B(99.20%)

RSV

8.00M(0.44%)

25.00M(0.80%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

Rest of the World

Europe

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

United States

1.20B(61.68%)

1.78B(55.16%)

1.90B(27.67%)

5.15B(26.74%)

6.18B(33.44%)

764.53M(95.16%)

Rest of the World

692.00M(35.60%)

853.00M(26.36%)

3.60B(52.54%)

7.30B(37.89%)

5.45B(29.49%)

38.87M(4.84%)

Europe

53.00M(2.73%)

598.00M(18.48%)

1.35B(19.79%)

6.82B(35.38%)

6.85B(37.06%)

--(--)